Larkspur Health Acquisition Corp - Ordinary Shares - Class A

NASDAQ:LSPR  
9.69
-1.05 (-9.78%)
7:43:49 PM EDT: $10.49 +0.80 (+8.26%)
Mergers / Acquisitions

Zyversa Therapeutics And Larkspur Health Acquisition Corp. Announce Business Combination, Interim Financing And Pipe Investment Update

Published: 09/27/2022 17:13 GMT
Larkspur Health Acquisition Corp - Ordinary Shares - Class A (LSPR) - Zyversa Therapeutics and Larkspur Health Acquisition Corp.
Announce Business Combination, Interim Financing and Pipe Investment Update.
Larkspur Health Acquisition Corp - Combined Company Expected to Be Named Zyversa Therapeutics, Inc. and Listed on Nasdaq Under Ticker "zvsa".
Larkspur Health Acquisition Corp - Aggregate Committed Financing in Support of Business Combination Now at $10.0 Million.
Larkspur Health Acquisition Corp - Pipe Investment is Anticipated to Close With Closing of Transaction, Which is Expected to Take Place in Q4 of 2022.